BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11136350)

  • 1. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients.
    Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
    Eur J Neurol; 2000 Nov; 7(6):647-53. PubMed ID: 11136350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
    Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
    Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell interferon gamma receptor binding in interferon beta-1b-treated patients with multiple sclerosis.
    Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
    Arch Neurol; 1999 Feb; 56(2):217-22. PubMed ID: 10025427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
    Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis.
    Bongioanni P; Mosti S; Moscato G; Lombardo F; Manildo C; Meucci G
    Arch Neurol; 1999 Jan; 56(1):71-8. PubMed ID: 9923763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis.
    Bongioanni P; Mosti S; Romano MR; Lombardo F; Moscato G; Meucci G
    Eur J Neurol; 2000 May; 7(3):291-7. PubMed ID: 10886312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
    Trenova AG; Manova MG; Kostadinova II; Murdjeva MA; Hristova DR; Vasileva TV; Zahariev ZI
    Folia Med (Plovdiv); 2011; 53(2):29-35. PubMed ID: 21797104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.
    Ossege LM; Sindern E; Patzold T; Malin JP
    Int Immunopharmacol; 2001 Jun; 1(6):1085-100. PubMed ID: 11407304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.
    Bakhiet M; Ozenci V; Withagen C; Mustafa M; Fredrikson S; Link H
    Clin Diagn Lab Immunol; 1999 May; 6(3):415-9. PubMed ID: 10225846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.
    Antonelli G; Simeoni E; Bagnato F; Pozzilli C; Turriziani O; Tesoro R; Di Marco P; Gasperini C; Fieschi C; Dianzani F
    J Neurol Sci; 1999 Oct; 168(2):131-6. PubMed ID: 10526196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis.
    Trenova AG; Slavov GS; Manova MG; Kostadinova II
    Arch Med Res; 2014 Aug; 45(6):495-500. PubMed ID: 25130430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis.
    Wang X; Chen M; Wandinger KP; Williams G; Dhib-Jalbut S
    J Immunol; 2000 Jul; 165(1):548-57. PubMed ID: 10861095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis.
    Totaro R; Passacantando A; Russo T; Parzanese I; Rascente M; Marini C; Tonietti G; Carolei A
    Int J Immunopathol Pharmacol; 2005; 18(2):377-83. PubMed ID: 15888259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
    Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.
    Rudick RA; Carpenter CS; Cookfair DL; Tuohy VK; Ransohoff RM
    Neurology; 1993 Oct; 43(10):2080-7. PubMed ID: 8105424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion.
    Dhib-Jalbut S; Jiang H; Williams GJ
    J Neuroimmunol; 1996 Dec; 71(1-2):215-22. PubMed ID: 8982122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.